Matinas BioPharma
MTNB
MTNB
55 hedge funds and large institutions have $18M invested in Matinas BioPharma in 2022 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $21.5M → $18M (-$3.49M)
Holders
55
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$226K | |
| 2 | +$170K | |
| 3 | +$88.3K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$63K |
| 5 |
Renaissance Technologies
New York
|
+$21K |
Top Sellers
| 1 | -$45K | |
| 2 | -$42.5K | |
| 3 | -$41.9K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$38.4K |
| 5 |
Jane Street
New York
|
-$18.5K |